118 related articles for article (PubMed ID: 17310092)
1. Autonomous proliferation of HTLV-CD4+ T cell clones derived from human T cell leukemia virus type I (HTLV-I)-associated myelopathy patients.
Miyano-Kurosaki N; Kira J; Barnor JS; Maeda N; Misawa N; Kawano Y; Tanaka Y; Yamamoto N; Koyanagi Y
Microbiol Immunol; 2007; 51(2):235-42. PubMed ID: 17310092
[TBL] [Abstract][Full Text] [Related]
2. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
3. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
[TBL] [Abstract][Full Text] [Related]
4. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones.
Wucherpfennig KW; Höllsberg P; Richardson JH; Benjamin D; Hafler DA
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2110-4. PubMed ID: 1549569
[TBL] [Abstract][Full Text] [Related]
5. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
6. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
7. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
8. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
10. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
[TBL] [Abstract][Full Text] [Related]
11. Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells.
Cavrois M; Gessain A; Gout O; Wain-Hobson S; Wattel E
J Infect Dis; 2000 Oct; 182(4):1044-50. PubMed ID: 10979898
[TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of TGF-beta 1 on the in vitro activation of HTLV-I and the proliferative response of CD8+ T lymphocytes in patients with HTLV-I-associated myelopathy (HAM/TSP).
Nagai M; Ijichi S; Hall WW; Osame M
Clin Immunol Immunopathol; 1995 Dec; 77(3):324-31. PubMed ID: 7586743
[TBL] [Abstract][Full Text] [Related]
14. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Hara H; Morita M; Iwaki T; Hatae T; Itoyama Y; Kitamoto T; Akizuki S; Goto I; Watanabe T
J Exp Med; 1994 Sep; 180(3):831-9. PubMed ID: 8064235
[TBL] [Abstract][Full Text] [Related]
15. Involvement of p38 MAPK signaling pathway in IFN-gamma and HTLV-I expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Yamada Y; Kohno S; Eguchi K
J Neuroimmunol; 2005 Feb; 159(1-2):196-202. PubMed ID: 15652420
[TBL] [Abstract][Full Text] [Related]
16. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.
Nose H; Kubota R; Seth NP; Goon PK; Tanaka Y; Izumo S; Usuku K; Ohara Y; Wucherpfennig KW; Bangham CR; Osame M; Saito M
J Infect Dis; 2007 Dec; 196(12):1761-72. PubMed ID: 18190256
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a unique T-cell clone established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens.
Nagai M; Yashiki S; Fujiyoshi T; Fujiyama C; Kitze B; Izumo S; Osame M; Sonoda S
J Neuroimmunol; 1996 Apr; 65(2):97-105. PubMed ID: 8964901
[TBL] [Abstract][Full Text] [Related]
19. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
20. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
Santos SB; Porto AF; Muniz AL; Luna T; Nascimento MC; Guerreiro JB; Oliveira-Filho J; Morgan DJ; Carvalho EM
Neuroimmunomodulation; 2006; 13(3):145-51. PubMed ID: 17119343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]